137 related articles for article (PubMed ID: 14367)
1. [Current pharmacological aspects of antithrombotic drugs].
Stroescu V
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1976; 28(5):325-7. PubMed ID: 14367
[No Abstract] [Full Text] [Related]
2. [Fundamental principles of hemostasis--oral antiplatelets and anticoagulants].
Morais D; Maranda G
J Dent Que; 1987 Apr; 24():201-7. PubMed ID: 3298345
[No Abstract] [Full Text] [Related]
3. [Mechanism of action of antithrombotic substances. General information about antagonistic and potentiating drugs].
Cornu P
Rev Prat; 1973 Dec; 23(60):5365-8 passim. PubMed ID: 4794529
[No Abstract] [Full Text] [Related]
4. [Blood platelets and cardiovascular diseases. IV. Platelet-inhibiting drugs and antithrombotic agents].
Jobin F
Union Med Can; 1976 Aug; 105(8):1159-73. PubMed ID: 10662
[No Abstract] [Full Text] [Related]
5. [Systemic effects of thrombolytic therapy].
Balduini CL; Gamba G; Bertolino G; Noris P; Previtali M; Ascari E
Haematologica; 1991 Jun; 76 Suppl 3():281-90. PubMed ID: 1752524
[No Abstract] [Full Text] [Related]
6. Mode of action of heparin and related drugs.
Hemker HC; Beguin S
Semin Thromb Hemost; 1991; 17 Suppl 1():29-34. PubMed ID: 1648791
[No Abstract] [Full Text] [Related]
7. [Effect of BM 15075 on the blood coagulation system and on interaction with oral anticoagulants].
Hoffrichter A; Zimmermann R; Walter E; Ehlers W; Andrassy K; Lang PD; Schlierf G; Weber E
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1584-6. PubMed ID: 347788
[No Abstract] [Full Text] [Related]
8. Anticoagulant activity of galactosaminoglucuronoglycan: a pharmacological study.
Matera M; Scalia S
Drugs Exp Clin Res; 1991; 17(1):65-73. PubMed ID: 1833172
[TBL] [Abstract][Full Text] [Related]
9. [Effect of ilexonin A on platelet function and ultrastructure].
Wang Z; Du JX
Zhong Xi Yi Jie He Za Zhi; 1985 Apr; 5(4):232-4, 197. PubMed ID: 3158445
[No Abstract] [Full Text] [Related]
10. Overview of hemostasis and thrombosis; current status of antithrombotic therapies.
Horne M
Thromb Res; 2005; 117(1-2):15-7; discussion 39-42. PubMed ID: 16055174
[No Abstract] [Full Text] [Related]
11. Blockade of glycoprotein IIb/IIIa mediates the antithrombotic activity of butanol fraction of Actinostemma lobatum Maxim.
Kim KH; Lee HJ; Lee JH; Jang YS; Kim DK; Shim BS; Cho KH; Ko SG; Ahn KS; Kim SH
J Ethnopharmacol; 2008 Mar; 116(3):431-8. PubMed ID: 18243609
[TBL] [Abstract][Full Text] [Related]
12. [Current state of anticoagulant and fibrinolytic therapy].
Hladovec J
Cas Lek Cesk; 1971 Oct; 110(42):969-75. PubMed ID: 5114558
[No Abstract] [Full Text] [Related]
13. [Effect of a blood extract on plasma lipids, blood coagulation, fibrinolysis and platelet aggregation in experimental hypercholesterolemia of rabbits].
Giarola P; Egge H; Gibelli A; Murawski U
Arzneimittelforschung; 1974 Jun; 24(6):925-8. PubMed ID: 4408049
[No Abstract] [Full Text] [Related]
14. Pharmacodynamics of a sulfated lactobionic acid amide-derived antithrombotic agent (Aprosulate) in primates.
Fareed J; Coker S; Iqbal O; Hoppensteadt D; Walenga JM
Semin Thromb Hemost; 1991; 17 Suppl 2():147-52. PubMed ID: 1948085
[No Abstract] [Full Text] [Related]
15. Ticlopidine as an experimental antithrombotic agent.
Vallée E; Maffrand JP; Bernat A; Delebassée D; Tissinier A
Agents Actions Suppl; 1984; 15():50-9. PubMed ID: 6592945
[No Abstract] [Full Text] [Related]
16. [New methods for detection of interaction of drugs acting on blood coagulation and blood platelets].
Breddin K; Basic-Micic M
Vasa Suppl; 1991; 33():79. PubMed ID: 1788772
[No Abstract] [Full Text] [Related]
17. Antithrombotic effects of naturally derived products on coagulation and platelet function.
Mousa SA
Methods Mol Biol; 2010; 663():229-40. PubMed ID: 20617421
[TBL] [Abstract][Full Text] [Related]
18. [Effects of thrombolysis on platelets and coagulation].
Helft G; Abdelouahed M; Vacheron A; Lecompte T; Samama MM
Ann Cardiol Angeiol (Paris); 1995 Sep; 44(7):354-60. PubMed ID: 8561440
[TBL] [Abstract][Full Text] [Related]
19. Slight differences in sulfation of algal galactans account for differences in their anticoagulant and venous antithrombotic activities.
Fonseca RJ; Oliveira SN; Melo FR; Pereira MG; Benevides NM; Mourão PA
Thromb Haemost; 2008 Mar; 99(3):539-45. PubMed ID: 18327402
[TBL] [Abstract][Full Text] [Related]
20. Coagulation inhibitors from blood-sucking animals. A new line of developing antithrombotic drugs.
Markwardt F
Pharmazie; 1994 May; 49(5):313-6. PubMed ID: 8016176
[No Abstract] [Full Text] [Related]
[Next] [New Search]
